Effects on hemolysis according to infusion rates
| Infusion rate (mL/hr) | Baseline | Terumo–post infusion | Baxter–post infusion | |||
|---|---|---|---|---|---|---|
| Plasma Hb (mg/dL) | %Hemolysis (%) | Plasma Hb (mg/dL) | %Hemolysis (%) | Plasma Hb (mg/dL) | %Hemolysis (%) | |
| 10 | 25.4±5.19 | 0.09±0.00 | 41.8±13.63 | 0.15±0.01 | 58.2±20.13 | 0.22±0.03 |
| 30 | 25.9±6.22 | 0.07±0.01 | 34.0±12.02 | 0.10±0.02 | 39.1±12.98 | 0.11±0.03 |
| 100 | 46.9±17.5 | 0.14±0.06 | 56.3±11.31 | 0.16±0.04 | 65.2±9.75 | 0.19±0.04 |
Values are presented as mean±standard deviation. Each number represents an average value of three samples. The instruments were from the following companies: Baxter Healthcare Corp. (Deerfield, IL, USA) and Terumo Medical Corp. (Tokyo, Japan).
Abbreviation: Hb, hemoglobin.